The Sequential Introduction of HIV-1 Subtype B and CRF01AE in Singapore by Sexual Transmission: Accelerated V3 Region Evolution in a Subpopulation of Asian CRF01 Viruses  by Kalish, Marcia L. et al.
The Sequential Introduction of HIV-1 Subtype B and CRF01_AE in Singapore by Sexual
Transmission: Accelerated V3 Region Evolution in a Subpopulation of Asian CRF01 Viruses
Marcia L. Kalish,*,1 Bette T. Korber,† Satish Pillai,† Kenneth E. Robbins,* Yee Sin Leo,‡ Ae Saekhou,* Iris Verghese,‡
Phillip Gerrish,*,2 Chee Leok Goh,§ Davis Lupo,* Boon Huan Tan,§,3 Teresa M. Brown,* and Roy Chan§
*Centers for Disease Control and Prevention, Atlanta, Georgia 30333; †Los Alamos National Laboratory, Los Alamos, New Mexico 87545;
‡Communicable Disease Centre, Singapore 308205; and §National Skin Centre, Singapore
Received April 16, 2002; returned to author for revision May 28, 2002; accepted July 26, 2002
The rapid spread of the human immunodeficiency virus type 1 (HIV-1) circulating recombinant form (CRF) 01_AE
throughout Asia demonstrates the dynamic nature of emerging epidemics. To further characterize the dissemination of these
strains regionally, we sequenced 58 strains from Singapore and found that subtype B and CRF01 were introduced separately,
by homosexual and heterosexual transmission, respectively. Protein similarity scores of the Singapore CRF01, as well as all
Asian strains, demonstrated a complex distribution of scores in the V3 loop—some strains had very similar V3 loop
sequences, while others were highly divergent. Furthermore, we found a strong correlation between the loss of a V3
glycosylation site and the divergent strains. This suggests that loss of this glycosylation site may make the V3 loop more
susceptible to immune surveillance. The identification of a rapidly evolving population of CRF01_AE variants should be
considered when designing new candidate vaccines and when evaluating breakthrough strains from current vaccine trials.
© 2002 Elsevier Science (USA)Asia.
INTRODUCTION
The greatest diversity of human immunodeficiency vi-
ruses has been identified in Africa (17, 20, 29, 47, 56),
where the introduction of these retroviruses into humans
was due to zoonotic infections (11, 22, 24, 60, 61). After
human immunodeficiency virus type 1 (HIV-1) variants
radiated out from Africa, numerous regional epidemics
occurred worldwide. Often the variants that dominated
these regional expansions had a low prevalence in Af-
rica. For example, subtype B viruses, which are infre-
quently found in Africa (40), were the first identified HIV-1
strains (1, 18), detected after their dissemination into the
Americas and Europe (28, 55). Subtype F1 viruses (80)
were first recognized after seeding an epidemic of pedi-
atric infections in Romania (16). One of the most inten-
sively studied of these regional epidemics, and the sub-
ject of this investigation, was the introduction and rapid
spread throughout Asia of subtype E viruses, now called
CRF01 (circulating recombinant form (CRF) 01_AE or
CRF01), with CM240 being a prototype strain CM240 (65,
1 To whom correspondence and reprints requests should be ad-
dressed at Centers for Disease Control and Prevention, 1600 Clifton
Road, Mailstop G19, Atlanta, Georgia 30333. Fax: (404) 639-3254.
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2 Present address: Theoretical Biology & Biophysics, MailStop K710,66). CRF01 isolates from 11 different countries in Asia are
currently available in the HIV sequence database (40).
The first reported strains of CRF01 were from Thailand
(54, 58, 59), and these strains were later found to be
related to a more diverse set of CRF01 viruses in the
Central African Republic (56). This variant is thought to
be a mosaic since its gag, pol, and most of its accessory
genes cluster with subtype A, but because most of the
external portion of gp160 and part of its LTR are very
distinctive from those of other subtype A viruses, it was
given the designation CRF (6, 21, 66, 67).
The epidemic in Southeast Asia was first recognized
in Thailand in 1988, when the prevalence of HIV (later
identified as subtype B) among injecting drug users
(IDUs) in Bangkok increased from 1 to 43% in 1 year
(10). By the following year, a similar explosive rise in
infections among female commercial sex workers
(CSWs) was noted, a rise that heralded the start of the
heterosexual HIV CRF01 epidemic (5, 50, 71, 72, 82). The
sequences from the early CRF01 epidemic in Thailand
were very conserved, particularly relative to the CRF01
sequences from the Central African Republic, suggesting
that a founder virus from the older African epidemic
seeded the CRF01 epidemic in Asia (55, 56, 77). What
originally appeared to be sequential waves of infections
beginning among IDUs and spreading sexually was laterKey Words: HIV-1; Singapore; CRF01_AE; V3 loop; envelo
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sions and of CRF01 viruses through sexual transmis-
sions (58, 59). A later study of the molecular epidemiol-
ogy of HIV among Bangkok IDUs highlighted the
dynamic nature of the dispersal of HIV strains within a
population. By 1994, the proportion of CRF01 infections
among IDUs infected with HIV less than 2 years had
increased to 44% (31), and from 1995–1998 the proportion
in new CRF01 IDU infections had increased to 80%
(78, 81).
To further study the dynamics of the emerging Asian
epidemic, as well as to track patterns in the evolution of
the viruses, we investigated the molecular epidemiology
and evolutionary relationships of HIV in Singapore. We
have documented that subtype B was transmitted pri-
marily by homosexual transmission and CRF01-AE by
heterosexual transmission. Further, we show that a sub-
population of CRF01 viruses are evolving at an acceler-
ated rate in the V3 region and that this rapid adaptation
is strongly correlated with the loss of a glycosylation site
within the V3 loop.
RESULTS
Patient demographics and clinical histories
Table 1 summarizes the demographic and clinical data
from the questionnaires filled out at the time the patients
underwent phlebotomy. Of the 58 samples that were
sequenced and analyzed, 26 samples were from hetero-
sexuals, 19 samples were from homosexuals, 10 sam-
ples were from bisexuals, 2 samples were from patients
with both IDU and heterosexual risk factors, and 1 sam-
ple was from a patient whose only risk for infection was
an organ transplant. Most of the patients were Chinese
(86%) and born in Singapore (79%). All but three (95%) of
the patients infected sexually were male, and 85% re-
ported having sex in other countries, primarily Thailand,
Malaysia, and Indonesia. Large numbers of sex partners
were reported regardless of risk group: 14 (25%) of the 55
persons infected sexually reported having more than 50
partners; 18 (33%) reported 20–50 contacts; 9 (16%) re-
ported 10–20 contacts; 7 (13%) reported 5–10 contacts;
and 7 (13%) reported fewer than 5 contacts. All three of
the women infected sexually reported having fewer than
five sex partners, and only one reported having sex
outside of Singapore (in Thailand). For most of the re-
spondents, the date of infection was unknown, so only
the date of first diagnosis of HIV infection is listed in
Table 1. The earliest documented infection among par-
ticipants in this study was in a homosexual male, known
to have been infected since 1988. The average age of all
patients was 39.5 years, and their mean CD4 count was
212.5. Patients infected with CRF01 had a mean age of 43
years (range 24–61) and a mean CD4 count of 237 (range
4–769); those with subtype B viruses had a mean age of
35.5 years (range 27–48) and a CD4 count of 189 (8–603).
Using a standard analysis of variance, we found the
average age of patients infected with CRF01 viruses was
significantly higher (P  0.0025) than that of patients
infected with subtype B viruses, but we found no signif-
icant difference in their CD4 counts (P  0.31).
Through phylogenetic analysis of the 58 env se-
quences, we found that strains fell into three different
group M subtypes or CRFs: B, CRF01, or C. Twenty-nine
of the sequences represented CRF01 infections, 28 were
subtype B, and 1 was subtype C. Only 3 (11%) of the 28
subtype B infections were due to the genetically distinct
subtype B variant (30). The one subtype C infection was
in a woman whose only risk for HIV infection was receiv-
ing an organ transplant in India, where subtype C infec-
tions dominate the HIV epidemic (46). Eighteen (95%) of
the 19 persons identifying themselves as having homo-
sexually acquired infections were infected with subtype
B viruses, but only 1 of these 18 with subtype B infections
had the B variant; 23 (88%) of 26 heterosexually trans-
mitted infections were due to CRF01 strains (Fig. 1). Of
the 10 bisexuals, half (50%) were infected with CRF01
and half were infected with subtype B viruses. The two
persons identifying themselves as IDUs were infected
with subtype B viruses, typical of the strains reported to
be predominant among Bangkok IDUs early in the Thai
epidemic. One B variant was found in a homosexual
male.
Phylogenetic analysis of the C2V3C3 region of gp120
To evaluate the evolutionary relationships of the Sin-
gapore HIV-1 strains, we performed phylogenetic analy-
sis on the C2V3C3 region of env and the p17 coding
region of gag for all strains. The results of a neighbor-
joining tree with bootstrapping for the C2V3C3 region is
shown in Fig. 2.
By comparing branch lengths, we were able to esti-
mate relative amounts of evolutionary change among
different lineages; we conducted bootstrap resampling of
2000 replicate trees to determine the robustness of the
branching order and observed groupings. A boot-
strapped neighbor-joining tree was constructed using
the subtype B reference strains MN and HXB2; the 1994
Thailand (TH) subtype B strains TH101, TH113, TH131,
TH132, TH133, TH139, TH149, and TH162 (31), the Central
African Republic (CAR) CRF01 strains CAR17, CAR39, and
CAR4071 (56); the Thailand 1994 CRF01 strains TH89,
TH100, and TH126; CRF01 reference strains CF402,
CM240, CARMBA; the subtype C reference strains BW05,
ZAM18, ETH2220, and IN21068; and the subtype F refer-
ence strain BR020 as an outgroup. Both subtype B and
CRF01 C2V3C3 sequences are represented in two sep-
arate star phylogenies. The branch lengths in each clus-
ter represent estimates of the extent of nucleotide
change that has occurred since the viruses most re-
cently shared a common ancestor. The branches of the
subtype B sequences are generally longer than those of
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TABLE 1
Demographic, Risk Factor, and Clinical Data
ID Clade Risk group CD4 Year diagnosed Sex Age Race Sex overseas No. of sex partners Country of birth
6218 B bi 10 Unk M 34 Ch TH, I 10–20 SG
6219 E he 343 1996 M 61 Ch TH 20–50 SG
6221 E he 202 1994 F 33 OT TH 5 OT
6265 B IDU, he 603 1992 M 38 MA MA 5–10 SG
6268 E he 20 1995 M 57 Ch TH, MA, IN, OT 10–20 SG
6269 B ho 8 1995 M 37 Ch None 5 SG
6270 B ho 91 1995 M 31 Ch TH, I 50 SG
6271 B bi 246 1994 M 36 Ch AU 10–20 SG
6273 B he 509 1993 M 41 In None 5–10 SG
6274 B ho 71 1994 M 31 Ch None 5–10 SG
6276 E bi 4 1995 M 40 Ch MA, I 50 SG
6278 B ho 17 1992 M 40 Ch None 5 SG
6280 B bi 161 1994 M 29 Ch MA 10–20 MA
6283 B ho 121 1994 M 44 Ch EU, AU, OT 50 SG
6286 C Organ 138 1995 F 38 Ch None Unk SG
6287 B bi 110 1995 M 27 In None 10–20 SG
6290 B ho 325 1992 M 35 Ch None 20–50 SG
6294 B ho 170 1993 M 37 Ch None 20–50 Unk
6295 B he 22 1994 M 37 Ch TH, I, OT 50 SG
6296 B bi 70 1994 M 48 Ch EU 10–20 SG
6302 B ho 411 1994 M 31 Ch U.S. 5 SG
6303 B ho 123 1990 M 42 In EU, AU, OT 10–20 SG
6309 E he 304 1993 M 61 Ch TH, MA, I, OT 50 OT
6315 E he 94 1996 M 43 In TH, OT 5–10 Unk
6316 E he 138 1993 M 33 Ch TH, MA, OT 20–50 SG
6318 E he 18 1994 M 34 Ch TH, MA 20–50 SG
6320 E bi 117 1995 M 31 Ch MA, I 50 SG
6323 E bi 396 1992 M 41 Ch None 20–50 SG
6324 E bi Unk 1996 M 24 Ch TH, MA 50 SG
6325 E he 243 1995 M 60 Ch TH, OT 50 SG
6326 E he 224 1996 F 49 Ch None 5 SG
6327 B ho 43 1989 M 35 Ch TH 20–50 SG
6329 B ho 45 1991 M 33 Ch TH-I-U.S.-EU-AU 20–50 SG
6330 E he 77 1991 M 37 Ch TH 20–50 SG
6332 E he 769 1995 M 34 Ch TH 50 SG
6334 E bi 346 1996 M 38 Ch TH 20–50 SG
6335 E ho 685 1994 M 42 Ch MA 50 SG
6336 E he 16 1995 M 29 Ch I 20–50 SG
6337 B IDU, he 256 1996 M 28 OT OT 20–50 OT
6339 E he Unk Unk M 50 Ch TH 50 SG
6341 E he 382 Unk M 35 Ch TH, MA 20–50 SG
6346 E he 355 1995 M 31 Ch TH, MA 20–50 SG
6347 B ho 322 1992 M 31 Ch MA, OT 20–50 SG
6348 B ho 114 1988 M 39 Ch EU, U.S. 20–50 SG
6349 E he Unk Unk M 50 Ch TH, MA 10–20 MA
6350 E he 18 1995 M 45 Ch TH 5–10 SG
6351 B ho 314 1996 M 33 Ch EU Unk SG
6352 B ho 343 1996 M 41 Ch IN, EU, AU 20–50 SG
6353 E he 212 1995 M 65 Ch TH, MA, I, AU 20–50 OT
6354 B ho Unk Unk M Ch OT 50 SG
6355 B he 42 1991 M 43 Ch TH, MA 10–20 SG
6357 E he 8 1994 M 46 Ch TH, I, MA 50 OT
6358 B ho 464 1995 M 28 Ch TH 5–10 SG
6359 B ho 339 1996 M 29 Ch None 5–10 SG
6360 E he 544 1996 F 26 OT TH 5 OT
6362 E he 594 1995 M 44 Ch TH, I, MA 50 OT
6363 E he 27 1996 F 62 Ch None 5 SG
6364 E he 34 1996 M 56 Ch TH, I 50 MA
Note. bi  bisexual; he  heterosexual; ho  homosexual; IDU  injecting drug user; Organ  organ transplant recipient; Ch  Chinese; Ma 
Malaysian; In  Indian; OT  other; Unk  unknown; SG  Singapore; TH  Thailand; MA  Malaysia; IN  India; I  Indonesia; EU  Europe;
AU  Australia; U.S.  United States.
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the Singapore CRF01 sequences, indicating that the sub-
type Bs are more divergent from each other than are the
CRF01 sequences. The longer branches could reflect an
earlier introduction or multiple introductions of the sub-
type B viruses, and these hypotheses are not mutually
exclusive. Within subtype B, the B viruses form a phy-
logenetically distinct subcluster (30). Through bootstrap
reconstruction of the branching order, we demonstrated
that all the subtype B viruses grouped together in 1680
(84%) of 2000 replicate trees as a subcluster within the
general subtype B clade (Fig. 2). The formation of this
monophyletic cluster within the B clade reflects the ep-
idemiologic relatedness of these viruses to the Asia
founder virus and the recent expansion of these strains.
The 1996 Singapore B strains have longer branches
than the 1994 Thailand B strains, reflecting the contin-
ued evolution of these viruses.
Within the CRF01 clade, the longer branches that we
observed in a subpopulation of Singapore CRF01 viruses
(such as SG6316, SC6320, SG6324, SG6325, and
SG6330) indicates that these sequences are more diver-
gent than the other 1996 Singapore CRF01 strains. The
degree of variation in these viruses is similar to that seen
in CRF01 viruses from the Central African Republic, sug-
gesting that there may be different subpopulations of
CRF01 viruses within our study population. As will be
discussed below, we observed this divergence only in
the V3 loop and not in p17. A similar pattern of diver-
gence, in a subset of V3 sequences, was noted previ-
ously in CRF01 sequences derived from AIDS patients in
northern Thailand (83).
Currently, infection with CRF01 viruses has been re-
ported throughout Asia (40), including cases in Japan,
Myanmar (Burma), Indonesia, Laos, Taiwan, Hong Kong,
Vietnam, Cambodia, Malaysia, and China, as well as in
Thailand. Some regions of Asia have a high prevalence.
When we constructed a C2V3C3 region neighbor-joining
tree based on 288 CRF01 sequences extracted from the
Los Alamos database, including our sequences along
with samples from studies conducted throughout Asia
and the Central African Republic, we found no particular
clustering of viral sequences associated with the Singa-
pore strains. The Asian CRF01 sequences were intermin-
gled in the tree, although the African and Asian se-
quences formed distinct clades (Fig. 3). Unlike the avail-
able Chinese sequences which form a distinctive
subcluster, the Singapore sequences do not appear to
be from a single founder virus. Instead, they seem to be
part of a more fluid pattern of forms circulating through-
out Asia. This is consistent with the epidemiology of HIV
being introduced into Singapore from sexual exposures
in other Asian countries where CRF01 strains predomi-
nate.
As discussed previously, the single subtype C se-
quence was more closely related to an India subtype C
strain than to related viruses from Zambia, Ethiopia, and
Botswana. This is consistent with the reports that the
only risk factor for infection in the patient, a child, was
receiving an organ transplant in India, where subtype C
viruses predominate.
Phylogenetic analysis of the p17 coding region of the
gag gene
We conducted phylogenetic analysis of p17 se-
quences (Fig. 4) to compare the tree topology or branch-
ing order with that of the C2V3C3 region. Reference
strains used in the neighbor-joining tree with bootstrap-
ping were subtype B strains MN and HXB2; 1991 subtype
B strains TH101, TH132, TH162; and subtype A strains
U455 and Q2317. Consistent with reports on the recom-
binant nature of CRF01 viruses (6, 21), p17 sequences
that were identified as subtype E in the C2V3C3 region
clustered with subtype A sequences (confirming their
A/E recombinant form). When compared with other sub-
type A p17 sequences from Africa, the Singapore se-
quences formed a distinct phylogenetic subcluster in
1880 (94%) of 2000 bootstrap replicates, reflecting their
FIG. 1. Subtype distribution in Singapore by risk group. Each pie chart represents the percentage of subtype B and CRF01_AE strains by
homosexual, heterosexual, and bisexual risk group.
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recent evolution from the founder virus that initiated the
Asian CRF01 epidemic. We observed no discordant tree
topologies, suggesting that a recombination event with
CRF01 had occurred among the subtype B sequences.
As discussed above, we observed long branch lengths
for S6G316, SG6318, SG6324, SG326, and SG330 CRF01
viruses in the V3 region sequences, suggesting that
these strains were more divergent. However, this greater
divergence was not reflected as long branches in the
corresponding p17 sequences, implying that the two
gene regions were evolving in different ways. In fact, the
branch length for SG330 was much shorter than that
seen for the majority of the Singapore subtype CRF01
p17 sequences, despite the divergent nature of its
C2V3C3 sequence.
Amino acid variation within the C2V3C3 region of env
in subtype B and CRF01 viruses
Figure 5 shows an alignment of the V3 and flanking
regions for the Singapore subtype B and B viruses, 1991
subtype B sequences from Thailand, and the subtype B
reference strains LAI and JRFL. The consensus se-
quence for subtype B was taken from the Los Alamos
database (35). Typical of subtype B viruses, there ap-
pears to be more variation in the regions immediately
FIG. 2. Phylogenetic reconstruction of Singapore HIV-1 C2V3C3 sequences with reference strains from CRF01_AE and subtypes B, B, C, and F1
(outgroup). Numbers at the nodes indicate the percentage of bootstrap values of 2000 replicates.
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FIG. 3. Phylogenetic reconstruction of CRF01 C2V3C3 sequences from HIV-infected persons living in Africa, Europe, the Americas, and Asia. The
outgroups are two subtype A sequences from the Central African Republic. Most Western CRF01 infections are probably of Asian origin, except the
French isolate, which clustered with the African CRF01s. There are scattered high bootstrap values throughout the tree between pairs and triplets
of sequences, and a 100% bootstrap value for the CRF01 clade compared to the A clade. The high bootstrap values (greater than 70%) for pairs of
sequences in most cases support associations from single nations, with the exception of sequences from China and Thailand. This is not surprising
given the short sequence length. The specific high bootstrap values in the tree are not marked as they were not particularly informative and the tree
branches are very dense. However the trends with nations in the tree are still of interest; the Chinese sequences form a distinctive clade, and the
African sequences group near the base of the tree.
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FIG. 4. Phylogenetic reconstruction of Singapore HIV-1 p17 sequences with reference strains from CRF01_AE and subtypes A, B, B, and F1
(outgroup). Numbers at the nodes indicate the percentage of bootstrap values out of 2000 replicates.
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flanking the third variable region than within the V3 loop
itself (31, 35), with the greatest number of mutations
occurring just downstream of V3. The GPGR motif at the
crown of the V3 loop is fairly conserved in subtype B
viruses, and this was true for the Singapore B viruses. In
previous reports of subtype B sequences, 13 (81%) of 16
Thailand B viruses collected in 1991 contained a GPGQ
motif (59), as did 39 (57%) of 69 Thai subtype B viruses
collected in 1994 (31). None of the three Singapore B
amino acid sequences contained the GPGQ motif, in-
stead, they all had a GPGR motif. For the “typical” sub-
type B sequences, 25 (86%) of 28 sequences had a GPGR
motif, 2 (7%) had a GPGK motif, and 1 (3.6%) had the
unusual GRGR motif.
An amino acid alignment of the CRF01 sequences is
shown in Fig. 6. Comparison of the amino acid se-
quences suggested two patterns of V3 loop sequences.
While the relative amount of amino acid substitutions,
distinct from the CRF01 consensus sequence, was sim-
ilar in all the flanking region sequences, one subset of V3
loop sequences had only few amino acid changes dis-
tinct from the consensus; the other had numerous sub-
stitutions. Many of these substitutions resulted in
changes to charged amino acids. One example involves
the predominant GPGQ motif at the crown of the V3 loop
of CRF01 viruses. In every case where there was a
mutation from the glutamine (Q), it was to one of the
charged amino acids, arginine (R) or histidine (H). In
addition, many of the amino acid substitutions in this
subset of divergent V3 sequences led to the loss of the
glycosylation site typically found at position 6–8 in the V3
loop, and often these also involved changes to charged
amino acids.
The role of the glycosylation site at positions 6–8 of
the V3 loop on the Singapore CRF01 viruses
Between 18 and 33 N-linked glycosylation sites have
been predicted in the gp120 protein of HIV-1 group M
viruses on the basis of the presence of glycosylation
sequons (38); this variation is mainly the result of inser-
tions and deletions in hypervariable regions in the env
gene. A potential glycosylation site (glycan) is deter-
mined from the sequon asparagine—any amino acid—
threonine or serine, N (X) T/S. The subtype B consensus
sequence contains eight predicted glycans in the region
that we have sequenced (Fig. 5). The second glycosyla-
tion site was missing in 19 (68%) of the 28 Singapore
subtype B sequences.
It has been reported previously that most sequences
of CRF01 viruses lack the fifth, sixth, and eighth glyco-
sylation sites, but that the fifth glycan is replaced just 2
amino acids downstream by a unique alternative glycan
(31, 56, 77). We also found that 10 (34%) of 29 CRF01
sequences lack the fourth glycosylation site, which be-
gins at the sixth position within the V3 loop; but it is
missing in only 1 (3.6%) of the 28 Singapore subtype B
sequences. Since glycans have the potential to mask
epitopes (7, 8, 49), and this glycosylation site is within the
V3 loop, we calculated pairwise comparisons for CRF01
C2V3C3 sequences with and without the site (Table 2).
We found that the C2V3C3 pairwise distances and dn/ds
ratios were greater for sequences without the glycosyl-
ation site (mean 0.1218, dn/ds 1.3337) than for those that
contained it (mean 0.0789, dn/ds 0.9776). We then calcu-
lated pairwise comparisons (Table 2) separately for the
V3 loop and flanking regions of CRF01 sequences. The
flanking regions were used as internal controls. We
found the distribution of diversity scores and dn/ds ratios
were essentially identical in the flanking regions (mean
0.0868, dn/ds 0.9004 with the glycosylation site; mean
0.0959, dn/ds 0.9776 without it), independent of the gly-
cosylation site, but extremely different within the V3 loop
depending on the presence or absence of the glycosyl-
ation site (mean 0.0627, dn/ds 1.1001 and mean 0.1841,
dn/ds 2.1712, respectively).
The influence of the glycosylation site at positions
6–8 of the V3 loop of 60 Asian CRF01 sequences
To determine the influence of this glycosylation site on
Asian subtype CRF01 protein sequences, we separated
V3 sequences that carried the site from those that did not
among a set of 60 CRF01 sequences from Thailand,
Taiwan, Vietnam, and Singapore extracted from the Los
Alamos database. Of these 60 sequences, 20 (33%)
lacked the glycosylation site, similar to the percentage
among Singapore CRF01 sequences. Of 126 subtype B
sequences from Thailand, Taiwan, and Vietnam, only 6
(5%) lacked the site. We also performed PIMA analysis
(34) on the 60 Asian subtype CRF01 sequences. PIMA
scores quantify the degree of similarity between se-
quences at the amino acid level. The lower the score of
a particular sequence, the more distant it is from the
consensus. As can been seen from the histogram in Fig.
7A, the V3 loops for the 60 Asian CRF01 sequences show
a wide range of PIMA scores with a complex distribution,
suggesting the presence of a diverse population of vi-
ruses. When we extracted the sequences that contain
the glycosylation site and analyzed them separately, the
resulting histogram illustrates that these sequences are
highly conserved and the distribution is unimodal (Fig.
7B). The bottom panel, a histogram representing Asian
CRF01 sequences lacking the glycosylation site, shows
that these sequences are far less conserved and have a
broad range of variation (Fig. 7C). If the distribution of
nonsynonymous substitutions for the histograms were
superimposed on one another, the broad, complex dis-
tribution of PIMA scores seen in Fig. 7A would be ap-
parent. We next performed an additional test to better
characterize the relationship between the mutational
pattern and charge and generated a single PIMA score
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for each CRF01_AE sequence by comparing it with the
CRF01_AE consensus sequence. Again, low PIMA
scores indicate multiple nonconservative substitutions
relative to the consensus. When we compared this score
with the net positive charge of each V3 loop, we found
that the variability of the amino acid sequence was
strongly correlated with a high net positive charge
(P  106).
In a further analysis using SNAP to track synonymous
and nonsynonymous substitutions for each codon in the
alignment, we found that the nonsynonymous substitu-
tions that dominate the V3 loop when the N-linked gly-
cosylation site is absent were focused on either side of
the tip of the V3 loop, focused in a region highly suscep-
tible to antibody binding (Fig. 8) (23, 84).
DISCUSSION
The first case of HIV infection in the island state of
Singapore was reported in May 1985 (9). From 1985 to
1990, most HIV infections were in homosexual males,
most of whom reported having had sex while in the
FIG. 6. Amino acid alignment of the Singapore CRF01_AE C2V3C3 sequences. Singapore sequences: 1990, 1993, and 1994 sequences from
Thailand; and strains from the Central African Republic are aligned against the 1995 subtype E (CRF01_AE) consensus sequence. Dashes (- - -) denote
identity with the consensus sequence, dots () represent insertions/deletions, carets (∧ ∧ ∧) locate potential N-linked glycosylation sites, and positions
in gray identify the glycosylation site at position 6 within the V3 loop. All Singapore sequences are identified by the number 96, indicating the year
of collection (1996), followed by the country code for Singapore (SG) and by four-digit sequence identifiers.
TABLE 2
Comparisons of Genetic Distance and Synonymous/Nonsynonymous Substitutions within CRF01 and Subtype B Viruses in p17 and C2V3C3
Subtype Gene region
Distance mean
(range)
Nonsynonymous
distance (dn)
Synonymous
distance (ds) dn/ds
Subtype B P17 0.0775 0.0558 0.1593 0.3503
(0.0317–0.1263) (0.0000–0.103) (0.0353–0.3452)
CRF01 P17 0.0329 0.0352 0.0545 0.6459
(0.0136–0.1924) (0.0103–0.0681) (0.0000–0.1364)
Subtype B C2V3C3 0.1232 0.1199 0.1376 0.8712
(0.0309–0.1924) (0.0353–0.1854) (0.0147–0.323)
CRF01 C2V3C3 0.0942 0.0971 0.0841 1.1543
(0.0304–0.2079) (0.0232–0.2252) (0.0139–0.2179)
Subtype B Flanking 0.1306 0.1284 0.1418 0.9055
(0.0359–0.1941) (0.0392–0.1980) (0.0218–0.2899)
CRF01 Flanking 0.0892 0.0880 0.0947 0.9292
(0.0309–0.1913) (0.0305–0.1791) (0.0178–0.2902)
Subtype B V3 loop 0.1077 0.1013 0.1348 0.7515
(0.0099–0.2682) (0.0128–0.2446) (0.0000–0.5839)
CRF01 V3 loop 0.1073 0.1212 0.0686 1.7667
(0.0000–0.3445) (0.0000–0.3718) (0.0000–0.2625)
CRF01 C2V3C3 with glycana 0.0789 0.0785 0.0803 0.9776
(0.0304–0.1475) (0.0232–0.1429) (0.0278–0.2179)
C2V3C3 without glycanb 0.1218 0.1291 0.0968 1.3337
(0.0751–0.2079) (0.0653–0.2252) (0.0422–0.1697)
Flanking with glycana 0.0868 0.0850 0.0944 0.9004
(0.0355–0.1913) (0.0334–0.1791) (0.0335–0.2902)
Flanking without glycanb 0.0959 0.0958 0.0980 0.9776
(0.0538–0.1532) (0.0563–0.1687) (0.0178–0.2132)
V3 loop with glycana 0.0627 0.0645 0.0586 1.1001
(0.0000–0.1585) (0.000–0.1561) (0.0000–0.2193)
V3 loop without glycanb 0.1841 0.2143 0.0987 2.1712
(0.0698–0.3445) (0.0813–0.3718) (0.0000–0.2625)
Note. The Asian CRF01 C2V3C3 sequences that were glycosylated at positions 6–8 within the V3 loop had dn/ds values that were indistinguishable
when the region flanking the V3 loop and the V3 loop were compared, (two-sided Wilcoxon rank sum P-value 0.7116, Z  0.3697) and the overall
selection pressure was indistinguishable in the two regions. On the other hand, in the V3 loop sequences without the glycosylation site, the dn/ds
ratio was roughly twice as high within the loop as it was in the flanking regions (two-sided Wilcoxon rank sum P-value 0.0000065, Z  4.5091), close
to neutral in the flanking regions and under strong positive selection in the loop. (See table and the figure with the histograms.)
a With glycan refers to sequences which contain the glycosylation site at positions 6–8 of the V3 loop.
b Without glycan refers to sequences which lack the glycosylation site at positions 6–8 of the V3 loop. Refer to Fig. 5 and 6 for location of the V3
loop.
321HIV IN SINGAPORE—IMPORTANCE OF V3 GLYCOSYLATION SITE
FIG. 7. Pairwise distributions of protein similarity scores for the CRF01V3 loop and the V3 flanking regions show that more divergent V3 loop
sequences are associated with the lack of the V3 internal glycosylation site. The sequences included here were the entire 1999 collection of Asian
CRF01 sequences from the HIV database that span the V3 loop and flanking regions. The set was restricted to include no more than one sequence
per patient. The full distribution and the median and interquartile range (IR) are shown. The sequences were divided into two regions: the V3 loop,
typically consisting of 35 amino acid residues, including two cysteine residues that form a disulfide bond to produce the loop; and 35 amino acids
flanking the loop (15 amino acids immediately adjacent to the amino-terminal side of the loop and 20 amino acids immediately adjacent to the
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FIG. 8. A comparison of synonymous vs nonsynonymous cumulative behavior, codon by codon, through the V3 region, for the CRF01 sequences
with and without the V3 glycosylation site. The slope of each line describes the rate of accumulation of synonymous vs nonsynonymous substitutions
as one scans across the V3 region using the subsets of CRF01 V3 loop sequences described in Fig. 6. The average number of either synonymous
or nonsynonymous substitution was calculated for each set for each codon, and this number is added to the cumulative score as one moves from
left to right. The synonymous substitutions (dashed lines) are accumulating at roughly the same rate for both the CRF01 set that contains the V3 loop
glycosylation site and the set that does not contain the glycosylation site. The steep slope of the solid black line near the center of the V3 loop reflects
a very high rate of accumulation of nonsynonymous distance in the subset of Asian CRF01 sequences lacking the glycosylation site in the V3 loop,
which is indicative of positive selection. The most rapid accumulation of nonsynonymous substitutions begins at the missing glycosylation site, just
inside of the amino-terminal side of the V3 loop; for the N-terminal part of the alignments, up to that point, the nonsynonymous substitutions track
almost perfectly for the two sets. The high substitution rate for the set lacking the glycosylation site spans the tip of the loop, which continues through
the C-terminal cysteine, at which point the two sets begin to track each other once again. (Although the cumulative line for the nonglycosylated set
is of course much higher beyond the V3 loop, the rates of nonsynonymous substitution as reflected by the parallel tracking of the lines beyond the
V3 loop indicates that the selective pressure is comparable in both sets.).
carboxyl-terminal side of the loop). Each of the two regions was aligned and scored for pairwise similarity by using a modified version of the PIMA
software package (70) that incorporates protein similarity scores based on amino acid substitution matrices from protein blocks (25, 33). (A) The
nonnormal distribution with a long tail of low protein similarity indicates that a subset of the Asian E subtype V3 loop sequences are more divergent
than the rest of the population. (B) The subset of V3 loop sequences containing a glycosylation site at position six is relatively highly conserved. (C)
The subset of V3 loop sequences lacking this glycosylation site is highly divergent. (D, E, F) The flanking regions of the V3 loop serve as an internal
control for this analysis. The flanks exhibit roughly the same distribution for the entire set, the glycosylated sequences, and the nonglycosylated
sequences, supporting the conclusion that the subset of V3 loop sequences lacking the glycosylation site may be under selective pressure to escape
detection by the immune system.
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United States, Europe, or Australia, where HIV infections
were due almost exclusively to subtype B viruses. In
early 1991, the epidemiology of HIV changed, with 74% of
all new infections resulting from heterosexual transmis-
sions. By October 1997, 694 Singapore residents were
reported to be HIV-infected, with 96% of the infections
occurring through casual sex or sex with prostitutes in
Singapore and overseas. In this study of the molecular
epidemiology of HIV-1 infections in Singapore in 1996,
we demonstrated that the subtype B and CRF01 viruses
were introduced and spread separately: subtype B
through homosexual transmission and CRF01 through
heterosexual transmission.
Studying the early dynamics of an evolving regional
epidemic involving viruses of more than one subtype
provides the opportunity to better understand the factors
that may influence the selective transmission of viruses
from one subtype within diverse risk groups, whether
those factors are behavioral, biological, or simply due to
chance. It also presents the opportunity to compare how
the viruses in each subtype are evolving within a popu-
lation having a fairly homogenous racial and genetic
background. The early occurrence of HIV infections
among homosexual men as early as the mid-1980s sug-
gests that subtype B viruses were introduced into Sin-
gapore early in the global HIV pandemic, and the greater
genetic diversity that we observed in both the env and
the p17 sequences of subtype B viruses suggests that
they may have been introduced into Singapore earlier
than CRF01. In addition, because homosexual men from
Singapore frequently traveled to countries where sub-
type B viruses were prevalent, multiple introductions of
these B strains most likely occurred also. This is consis-
tent with the hypothesis of an early, global founder effect
in the rapid dissemination of subtype B viruses by ho-
mosexual transmission (41).
In contrast, the first recorded date of heterosexual
infection in Singapore was in 1991, only 1–2 years after
the CRF01 epidemic began in Thailand (58, 59, 72, 82).
When reporting their travel histories, most heterosexuals
in Singapore documented overseas trips to countries
within Southeast Asia, where CRF01 viruses account for
most heterosexually acquired infections. Whether there
are biological differences among subtype B and CRF01
viruses that may explain this apparent segregation re-
mains to be determined (15, 51–53, 62, 63, 74). Nonethe-
less, the epidemiologic evidence seems sufficient to
conclude that the earlier and most likely multiple intro-
ductions of subtype B viruses occurred through homo-
sexual transmissions and that the later introduction of
CRF01_AE viruses occurred through heterosexual trans-
mission.
Comparing the synonymous and nonsynonymous pair-
wise distances provides a means of assessing evolu-
tionary rates and the role of selection in the evolution of
different gene regions within and between subtypes. The
balance of positive and negative selective pressures
within a host are not equal for all genes or gene regions,
hence, they do not evolve at the same rate (4, 69). While
env is more variable than gag and pol, within each gene
there are regions of greater or lesser variability, i.e., the
p17 coding region of gag is more variable than p24 (4).
The similar dn/ds ratios for the regions flanking the V3
loop were the same for subtype B and CRF01, demon-
strating they are evolving at a constant rate. However, we
observed two patterns in the CRF01 V3 loop relative to
the subtype B sequences: either highly conserved or
very divergent. Hence, a subset of Asian V3 loop se-
quences are evolving more rapidly than the rest of the V3
region. When evaluating the role of the highly conserved
glycosylation site at positions 6–8 within the V3 loop, we
observed that 34% of our Singapore CRF01 viruses
lacked this site. Glycans have been reported to play an
important role in antibody recognition, viral infectivity,
cellular host range, and coreceptor usage (2, 3, 13, 44,
45, 49); more importantly, they have been reported to
mask epitopes (2, 3). Therefore, we hypothesized that
viruses lacking the glycan would be more susceptible to
immune surveillance, i.e., that the V3 loop of these vi-
ruses would be under constant selective pressure to
mutate and escape immune recognition. Indeed, we
found that the V3 loops of sequences lacking the glyco-
sylation site had higher dn/ds ratios in the V3 loop than
did the sequences containing the glycosylation sites,
while the flanking regions from strains with and without
the site displayed equal rates of evolution. When we
extended our analysis to include 60 CRF01 sequences
from Thailand, Taiwan, Vietnam, and Singapore and 126
subtype B sequences from Thailand, Taiwan, and Viet-
nam, we found a complex distribution of protein similarity
scores for all CRF01 sequences, including those from
Africa (14, 34). We found that V3 protein sequences were
highly conserved in viruses that contained the glycosyl-
ation site, but those without the site showed a broad
range of divergent sequences. It has recently been re-
ported that mutations leading to substitutions with pos-
itively charged amino acids in this glycosylation site can
also have an influence on changing CRF01 viruses from
NSI to SI phenotypes (33, 68), further confirming the
important role for this glycan in the evolution of the V3
loop of CRF01 viruses. In our study, we found a high
positive charge as well as the lack of the glycosylation
site to be related to V3 amino acid diversity. A plausible
hypothesis that accounts for all of our observations is
that the lack of the glycosylation site and the positive
charge reflect CXCR4 coreceptor usage, and that the V3
loop in these viruses is thus exposed to more intense
immune surveillance. Positive selection caused by im-
mune escape would account for the greater diversity
near the tip of the loop that we found in these viruses.
In conclusion, we have shown that subtype B and
CRF01 were introduced into Singapore sequentially, sub-
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type B through homosexual transmission, and CRF01
through heterosexual transmission. We also determined
that a subpopulation of CRF01 viruses were evolving
more rapidly in the V3 region and that the loss of a
glycosylation site within the V3 loop is strongly associ-
ated with this accelerated adaptation. This type of study
is important for countries interested in participating in
vaccine trials. Thailand was selected as one of the first
vaccine trial sites, in part because the Thai CRF01 and
subtype B epidemic was recently introduced from a
single founder virus, and the strains were genetically
very similar. However, the existence of this subpopula-
tion of CRF01, whose V3 region is evolving more rapidly,
may present an unanticipated challenge to the develop-
ment of CRF01 vaccines based solely on gp120. To
gauge the extent of this challenge, researchers will need
to determine whether there are biological as well as
genotypic differences between persons infected with
this more rapidly evolving subpopulation of CRF01
strains and those infected with strains evolving more
slowly. These rapidly evolving viruses should also be
considered when evaluating breakthrough strains from
CRF01 vaccine trials.
MATERIALS AND METHODS
Subjects
Whole blood specimens from 105 HIV-1-infected per-
sons were collected from patients attending the HIV
clinic at the Communicable Disease Centre, Singapore.
The only criterion for inclusion into the survey was a
known HIV-positive infection status. Patient forms con-
taining demographic data, risk information, and latest
CD4 count was filled out at the time of blood collection
(summarized in Table 1), and the patients’ signed in-
formed consent was received. Data and blood samples
were coded and sent to the U.S. Centers for Disease
Control and Prevention (CDC) as blinded samples.
Viral DNA isolation, amplification, and sequencing
All samples were initially processed in the National
Skin Centre, Singapore before being shipped to CDC.
Eight milliliters of whole blood was collected from HIV-
infected patients into the Vacutainer CPT Cell Prepara-
tion Tube with sodium citrate (Becton–Dickinson, Frank-
lin Lakes, NJ) and centrifuged according to the manu-
facturer’s instructions. The blood specimens were
processed within 2–3 h of collection. Briefly, the contents
of the tubes were mixed by gently inverting the tubes 8 to
10 times and centrifuging them at 1500 to 1800 g at room
temperature for 20 min. The plasma layer above the band
of peripheral blood mononuclear cells (PBMCs) in Ficoll–
Hypaque was discarded. The band of PBMCs and Ficoll–
Hypaque from above the gel plug was removed to a
15-mL tube, and 1.0 mL of prewarmed red blood cell
osmotic buffer, pH 7.4 (prepared by mixing 18 mL 0.17 M
NH4Cl with 2 mL 0.16 M Tris), was added. After the tubes
stood for 10 min at room temperature, 9 mL PBS was
added and mixed, and the tubes were spun at 250 g at
room temperature for 15 min. The supernatant was dis-
carded. To the residual cells, 0.5 mL PCR lysis buffer (50
mM KCl, 10 mM Tris–HCl, pH 8.3, 2.5 mM MgCl2, 25 M
EDTA, 0.45% NP-40, and 0.45% Tween 20) containing 60
M/mL Proteinase K was added. The cells were lysed at
56°C for 1 h and at 95°C for another 15 min. The ex-
tracted DNA specimens were stored at 20°C. Fifty-
eight DNA lysates from samples with sufficient cell pel-
lets were used in nested polymerase chain reactions
(PCRs) as previously described (31). Amplified products
were approximately 720 bp starting in the C2 region of
the env gene and terminating at the end of gp120, and
approximately 474 bp beginning upstream and spanning
the length of the p17 coding region of the gag gene.
Primers for the C2V3C3 were MK603 (5 AGAAAAATG-
GTGGGTCACAGTCTATTATGGGGTACCT 3) and CO602
(5 GCCCATAGTGCTTCCTGCTGCTCCCAAGAACC 3) for
primary PCR, and primers MK650 (5 ATGTCAGCACAG-
TACAATGTACAC 3) and MK601 (5TTCTCCAATTGTC-
CCTCATATCTCCTCCTCCA 3) for nested PCR. The p17
primers were CL1028 (5 TCTCTAGCAGTGGCGCCC-
GAACAGGGAC 3) and CL1033 (5 TCTATCCCATTCTG-
CAGCTTCCTCATTGAT 3) for primary PCR, and primers
CL1029 (5 TTTGACTAGCGGAGGCTAGA 3) and CL1032
(5 GGTGATA TGGCCTGATGTACCATTTGCCCCTG 3) for
nested PCR.
PCR products were purified with the Qiagen PCR pu-
rification spin kit (Qiagen, Inc., Chatsworth, CA), and the
DNA was sequenced according to the Taq dye termina-
tor method (Applied Biosystems, Inc., Foster City, CA).
Primers used for sequencing approximately 345 bp of the
C2V3C3 region of env were KR207 (5 TGTTAAATG-
GCAGTCTAGC 3) and MK650. Sequencing primers for
sequencing the approximately 396 bp of p17 included
CL1029, CL1032, and CL1030 (5 AGACAGGATCAGAA-
GAA 3).
Genetic and phylogenetic analysis
For determining subtype classification and phyloge-
netic relationships, sequence comparisons for the 28
subtype B and 29 CRF01 strains were performed by
using the C2V3C3 region of env and the p17 coding
region of gag. The sequences were manually aligned
with the sequence editor function of the Genetic Data
Environment (GDE) package. Sites where there was a
gap in any of the sequences or ambiguous positions in
the alignment were excluded from phylogenetic analysis.
The Molecular Evolution Genetic Analysis (MEGA) pro-
gram (42) was used to perform pairwise nucleotide com-
parisons of the sequences, and Synonymous Nonsyn-
onymous Analysis Program (SNAP) (36) was used to
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estimate synonymous (ds) and nonsynonymous (dn) dis-
tances calculated by the method (57). ds is the number of
observed synonymous substitutions divided by the num-
ber of possible synonymous substitutions and dn is the
number of observed nonsynonymous substitutions di-
vided by the number of possible nonsynonymous substi-
tutions. The nonparametric Wilcoxon rank sum test sta-
tistic was used to compare the used distributions of
dn/ds values in the glycosylated and nonglycosylated V3
loop. All pairwise comparisons of sequences were used
to obtain the average dn/ds values presented in Table 2,
but the non-independence of points and inflated appar-
ent sample size make the sets of all pairwise compari-
sons inappropriate for statistical comparisons. To ad-
dress this problem, the average dn/ds value was ob-
tained for each sequence compared to all others, and
thus, one dn/ds value was assigned to each sequence
for use in the final comparison.
For phylogenetic tree analysis, separate nucleotide
alignments for Singapore env C2V3C3 (n  58) and p17
(n  56) sequences were performed with the Se-Al
sequence alignment editor v.1.0 (64). HIV reference
strains from subtypes A, AE, B, B, C, and F were incor-
porated into the alignments. Alignments were saved with
removal of nucleotide positions containing gaps (336 bp
for the C2V3C3 alignment and 363 bp for the p17 align-
ment). The Modeltest program (64) was used with each
alignment to test for a statistically justified model of DNA
substitution for use in the phylogenetic tree-building pro-
gram. The model chosen in each case by the program
was used as the DNA substitution model in the bootstrap
(2000 replicates) (25); the neighbor-joining methodology
was implemented in PAUP (79). The Singapore sequence
data were deposited in GenBank under Accession Nos.
AF385955–AF386067 and AF417200.
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